跳至主要内容
临床试验/ISRCTN18989217
ISRCTN18989217进行中(未招募)未知

ong-term sustainability of a de-implementation project to Reduce Inappropriate Use of CATheters

Amsterdam University Medical Centers0 个研究点目标入组 1,254 人开始时间: 2022年2月11日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
1,254

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Adult patients admitted to internal medicine, gastroenterology, geriatric, oncology, and pulmonology wards, and non-surgical acute admission units who have a PVC or urinary catheter on the day of data collection, or
  • 2. Healthcare workers (e.g., nurses, physicians) who are or who were responsible for maintaining the de-implementation strategy to reduce inappropriate use of catheters

排除标准

  • 1. Patients who are admitted for an elective short stay, and patients who are terminally ill
  • 2. Patients with chronic use of catheters, defined as having any type of catheter before hospital admission, and no new inserted catheter of any type

研究者

发起方
Amsterdam University Medical Centers

相似试验

已完成
3 期
Effect of Mindfulness-based Stress Reduction (MBSR) on mood disordersCondition 1: Depression. Condition 2: Anxiety. Condition 3: Stress. Condition 4: Occupational burnout.Major depressive disorder, single episodeOther anxiety disordersBurn-outZ73.0
IRCT20190604043813N3Shiraz University of Medical Sciences68
招募中
不适用
Feasibility, effectiveness, and sustainability of an individualized app-based exercise program for patients with low back pain: a randomized controlled trial.M54.5Low back pain
DRKS00029099Hochschule für Gesundheit213
尚未招募
2 期
Effectiveness of Reusable Menstrual Pads as a Sustainable Alternative to Disposable Pads among Secondary School Students in Kano, Nigeria
PACTR202407662708627OXFORD UNIVERSITY84
进行中(未招募)
1 期
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical TrialsMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMultiple Sclerosis
EUCTR2019-000069-19-SEMerck KGaA1,000
进行中(未招募)
1 期
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical TrialsMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMultiple Sclerosis
EUCTR2019-000069-19-ITMERCK KGAA662